Dermata Therapeutics, Inc. (DRMA) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $6.22M | +298.7% |
| 2024 | $1.56M | -75.4% |
| 2023 | $6.36M | +5.5% |
| 2022 | $6.02M | -40.4% |
| 2021 | $10.11M | +418.0% |
| 2020 | -$3.18M | -1412.2% |
| 2019 | -$210.2K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $6.22M | +298.7% |
| 2024 | $1.56M | -75.4% |
| 2023 | $6.36M | +5.5% |
| 2022 | $6.02M | -40.4% |
| 2021 | $10.11M | +418.0% |
| 2020 | -$3.18M | -1412.2% |
| 2019 | -$210.2K | — |